Presenter:  Elias Chahine, PharmD, BCPS, Assistant Professor of Pharmacy Practice, Lloyd Gregory School of Pharmacy. 

Learning Objectives:  Upon completion of this activity pharmacists will be able to: Define Clostridium difficile infection; Identify the most common risk factors for Clostridium difficile infection; Describe the pathophysiology of Clostridium difficile infection; Identify signs and symptoms of Clostridium difficile infection; Compare and contrast the available treatment options for Clostridium difficile infection; Given a specific patient, recommend the most appropriate treatment for Clostridium difficile infection; Assess safety and efficacy of the therapeutic regimens used in the treatment of Clostridium difficile infection; State five strategies to control the spread of Clostridium difficile. 

UAN:  0165-0000-12-073-L01-P

Consultant Approval Number: PSC365166

Presenter:  Elias Chahine, PharmD, BCPS, Assistant Professor of Pharmacy Practice, Lloyd Gregory School of Pharmacy. 

Learning Objectives:  Upon completion technicians should be able to: Define Clostridium difficile; List C difficile risk factors; Recognize treatment options for C difficile.

UAN:  0165-0000-12-073-L01-T

Presenter:  Lisa Inge, PharmD, BCPS, BCACP, AAHIVE, University of Florida, Clinical Associate Professor, Department of Pharmacotherapy & Translational Research. 

Learning Objectives:  Upon completion of this activity pharmacists will be able to:  Describe the epidemiology of the infection; List the risk factors associated with viral transmission; Identify the combination of medications prescribed for HCV treatment; Explain a pharmacist’s potential role in therapeutic management of HCV. 

UAN:  0165-0000-12-074-L01-P

Presenter:  Elias Chahine, PharmD, BCPS, Assistant Professor of Pharmacy Practice, Lloyd Gregory School of Pharmacy. 

Learning Objectives:  Upon completion of this activity pharmacists will able to: Describe the epidemiology of sexually transmitted diseases; Describe the five Ps approach to interviewing patients about sexually transmitted diseases; Identify the most common etiologies of sexually transmitted diseases; Identify signs and symptoms of sexually transmitted diseases; Recommend the most appropriate antimicrobial regimen for the treatment of sexually transmitted diseases given a scenario; Assess efficacy and safety of commonly used regimens in the treatment of sexually transmitted diseases; State four strategies to prevent sexually transmitted diseases. 

UAN:  0165-0000-12-075-L01-P

Consultant Approval Number:  PSC365166

Presenter:  Elias Chahine, PharmD, BCPS, Assistant Professor of Pharmacy Practice, Lloyd Gregory School of Pharmacy. 

Learning Objectives:  Upon completion technicians will be able to: Define common STDs; Identify risk factors; Recognize signs and symptoms; List treatment options.

UAN:  0165-0000-12-075-L01-T

Presenter:  Timothy Gauthier, PharmD, BCPS, Assistant Professor, Pharmacy Practice, NOVA Southeastern College of Pharmacy.

Learning Objectives:  Upon completion of this activity pharmacists will be able to:  Identify free antibiotic programs; List pros and cons of free antibiotic programs; Recognize the importance of antimicrobial resistance; List resources available to assist pharmacists for managing antimicrobial agents. 

UAN:  0165-0000-12-076-L04-P

Presenter:  Michael Jackson, RPh, CPh, Florida Pharmacy Association CEO & EVP

Learning Objectives:  Upon completion of this activity pharmacists will be able to: Define elements of a Continuous Quality Improvement Program; Restructure a pharmacy practice to address quality related events; Analyze some common causes of quality related events; Implement an action plan to address quality of care in pharmacies with a goal towards error reduction and prevention; Recite quality improvement regulations for Florida pharmacies. 

UAN:  0165-0000-12-027-L05-P

Board Approval Number:  PSM346256

Presenter: Jacqueline Jourjy PharmD, BCPS, LECOM  Bradenton School of Pharmacy, Assistant Professor of Pharmacy Practice. 

Learning Objectives:  Upon completion of this activity pharmacists will be able to:  Define acute bacterial rhinosinusitis (ABRS) and community-acquired pneumonia (CAP); Explain the usual clinical presentation of ABRS and CAP; List the common etiologies of ABRS and CAP; Identify which antimicrobial agents are recommended first-line and as alternatives for the empiric treatment of ABRS and CAP; Discuss the clinical relevance and impact of antimicrobial resistance as it relates to ABRS and CAP; Assess a patient case to determine the most appropriate treatment regimens for ABRS and CAP. 

UAN:  0165-0000-12-077-L01-P

Consultant Approval Number:  365166

Presenter: Jacqueline Jourjy PharmD, BCPS, LECOM  Bradenton School of Pharmacy, Assistant Professor of Pharmacy Practice

Learning Objectives: Upon completion technicians will be able to: Define ABRS and CAP; Identify signs and symptoms associated with ABRS and CAP; List medications used to treat ABRS and CAP.

UAN:  0165-0000-12-077-L01-T

Presenter:  Michael Thompson, PharmD, BCNSP, Florida A & M University, Dean and Professor of Pharmacy Practice.

Learning Objectives:  Upon completion of this activity pharmacistswill be able to: Discuss the epidemiology and clinical features of MRSA infection;Identify and discuss various non-pharmacologic and pharmacologic measures toreduce transmission of MRSA infection; Discuss the current pharmacotherapy ofresistant staphylococcal infection; Develop a pharmacotherapy plan to treatMRSA in both community and institutional settings. 

UAN:  0165-0000-12-078-L01-P

Presenter:  Saumil Patel, PharmD, BCPS, Pediatric Pharmacotherapy Specialist, Tampa General Hospital. 

Learning Objectives:  Upon completion of this activity pharmacists will be able to:Provide an overview of current trends of common acquired pediatric infections;Discuss current trends in management strategies of common acquired pediatricinfections; Review vital recent and upcoming changes in immunizations toaccommodate for the projected trends in pediatric infections; Evaluate the role of a pharmacist in managing upcoming pediatric infections and immunizations. 

UAN:  0165-0000-12-079-L01-P

Consultant Approval Number:  PSC365166

Presenter:  Saumil Patel, PharmD, BCPS, Pediatric Pharmacotherapy Specialist, Tampa General Hospital

Learning Objectives:  Upon completion technicians will be able to: List common pediatric infections; Identify medications used to treat pediatric infections; Recognize recent changes in pediatric immunizations. 

UAN:  0165-0000-12-079-L01-T

Presenter:  Jennifer Pytlarz,  PharmD, BCACP, University of South Florida, Assistant Professor,  Department of Pharmacotherapeutics & Clinical Research

Learning Objectives:  Upon completion of this activity pharmacists will be able to: Describe recent changes to immunization schedules and recommendations; List information resources necessary to stay up-to-date with immunization practices; Outline recent changes to Florida legislation regarding pharmacist-delivered immunizations; Describe immunologic characteristics of several vaccine-preventable diseases in the U.S.; Review the use of influenza, pneumococcal and zoster vaccines.

UAN:  0165-0000-12-080-L01-P 

Presenter:  Sami Shafiq, PharmD, CPh, AAHIVE, Lead HIV/AIDS Clinical Pharmacist, Miami Market , Walgreens, Clinical Assistant Professor of PharmacyPractice for Nova Southeastern University/Palm Beach Atlantic University. 

Learning Objectives:  Upon completion of this presentation pharmacists will able to:  Review current modes of transmission; Identify high risk behaviors; Discuss the pharmacist role in providing care for HIV infected patients; Describe the mechanism of actions of antivirals; Describe the rationale behind combination therapies; Interpret current Florida laws on HIV/AIDS

UAN:  0165-0000-12-010-L02-P